Literature DB >> 33244176

Does MRI-guided TULSA provide a targeted approach to ablation?

Rohith Arcot1, Thomas J Polascik2.   

Abstract

Year:  2021        PMID: 33244176     DOI: 10.1038/s41585-020-00403-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Reply by Authors.

Authors:  Laurence Klotz; Christian P Pavlovich; Joseph Chin; Gencay Hatiboglu; Michael Koch; David Penson; Steven Raman; Aytekin Oto; Jurgen Fütterer; Marc Serrallach; James Relle; Yair Lotan; Axel Heidenreich; David Bonekamp; Masoom Haider; Temel Tirkes; Sandeep Arora; Katarzyna J Macura; Daniel N Costa; Thorsten Persigehl; Allan J Pantuck; Joyce Bomers; Mathieu Burtnyk; Robert Staruch; Scott Eggener
Journal:  J Urol       Date:  2020-12-23       Impact factor: 7.450

2.  Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.

Authors:  Shiva M Nair; Gencay Hatiboglu; James Relle; Khalil Hetou; Jason Hafron; Christopher Harle; Zahra Kassam; Robert Staruch; Mathieu Burtnyk; David Bonekamp; Heinz-Peter Schlemmer; Matthias C Roethke; Maya Mueller-Wolf; Sascha Pahernik; Joseph L Chin
Journal:  BJU Int       Date:  2020-10-09       Impact factor: 5.588

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.